PROFUND ADVISORS LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 316 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.

Quarter-by-quarter ownership
PROFUND ADVISORS LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$1,541,007
-8.4%
29,431
-28.8%
0.06%
-12.3%
Q1 2024$1,681,955
+6.1%
41,346
-3.6%
0.06%
-4.4%
Q4 2023$1,585,732
-6.2%
42,904
-3.0%
0.07%
-26.9%
Q3 2023$1,690,426
-6.7%
44,252
-11.9%
0.09%
-4.1%
Q2 2023$1,811,471
+28.4%
50,221
+36.0%
0.10%
+11.5%
Q1 2023$1,410,280
+9.1%
36,928
+62.6%
0.09%
+3.6%
Q4 2022$1,292,313
+43.4%
22,712
-0.3%
0.08%
+29.2%
Q3 2022$901,000
-11.8%
22,788
-1.9%
0.06%0.0%
Q2 2022$1,022,000
-5.8%
23,230
-14.7%
0.06%
+41.3%
Q1 2022$1,085,000
-11.0%
27,218
-10.2%
0.05%
+15.0%
Q4 2021$1,219,000
-12.0%
30,312
-11.0%
0.04%
-14.9%
Q3 2021$1,386,000
+171.2%
34,067
+203.5%
0.05%
+176.5%
Q2 2021$511,000
+12.3%
11,223
+2.8%
0.02%0.0%
Q1 2021$455,000
-14.3%
10,916
-12.2%
0.02%
-26.1%
Q4 2020$531,000
-2.2%
12,427
-80.3%
0.02%
-11.5%
Q2 2016$543,000
-10.8%
62,971
-2.1%
0.03%
-18.8%
Q1 2016$609,000
-56.2%
64,341
-19.8%
0.03%
-51.5%
Q4 2015$1,389,000
+28.7%
80,177
-0.2%
0.07%
+8.2%
Q3 2015$1,079,00080,3560.06%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Third Security, LLC 19,816,162$195,784,0009.33%
BB BIOTECH AG 5,846,564$57,764,0002.74%
QVT Financial LP 4,556,090$45,014,0002.44%
Parametrica Management Ltd 29,578$292,0002.21%
SECTORAL ASSET MANAGEMENT INC 4,389,682$43,370,0001.84%
Belmont Global Advisors, Inc. 257,000$2,539,0001.83%
HARVEY CAPITAL MANAGEMENT INC 394,550$3,898,0001.40%
Lombard Odier Asset Management (USA) Corp 1,350,000$13,338,0000.70%
IRIDIAN ASSET MANAGEMENT LLC/CT 6,199,685$61,253,0000.63%
Callan Capital, LLC 199,230$1,968,0000.53%
View complete list of HALOZYME THERAPEUTICS INC shareholders